Diligence memo · auto-generated · as of July 2, 2026

Health Gorilla, Inc.

Health Gorilla, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Health Gorilla, Inc. operates in Healthtech, based in Palo Alto.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Health Gorilla, Inc. has raised $59M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $50M on 2022-02-16.

Most recent recorded round closed around 2022-02-16.

Valuation (modeled)modeled

Provath models Health Gorilla, Inc. at approximately $816M (range $182M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.68× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 41 months.

Last raise 4.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 7.9× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 92% of Healthtech peers (2138 compared).

Modeled value ranks above 96% of those peers.

Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Hazel Health, Inc., Employee Health Holdings, LP.

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.